Should Your Eye Care Practice Use Performance Max? An Honest Assessment

Should Your Eye Care Practice Use Performance Max? An Honest Assessment

Should Your Eye Care Practice Use Performance Max? An Honest Assessment

Your Google rep called twice last month to recommend shifting 40% of your Search budget to Performance Max. Your agency is warming to the idea. The deck shows the same 27% conversion lift Google publishes in every pitch. What nobody mentions is whether those conversions become actual patients.

This article covers the honest case for and against PMax in eye care. Where it earns budget, where it leaks it, and how to test before you commit the pipeline.

Why Performance Max Is the Wrong Default for Eye Care Lead Gen

Google salespeople and most agencies will tell you Performance Max is the future. For eye care lead generation, the evidence says it is the wrong tool for most campaigns most of the time. This is the piece most decks do not include.

PMax optimizes for whatever conversion event you define, and it optimizes relentlessly. If the conversion event is “form submitted,” the algorithm gets very good at finding people who submit forms. Form-fillers who never book surgery are, from Smart Bidding’s perspective, a feature. The algorithm is doing its job. The job is just not aligned with your business.

For ecommerce, where volume compensates for variance and the conversion event is the revenue event, PMax works well. For lead-gen healthcare, where the conversion event (form fill) precedes the revenue event (booked consult, completed procedure) by weeks or months, the alignment breaks. The automation that helps ecommerce actively hurts eye care practices that use PMax without closing the loop.

The honest case requires looking at the numbers, the mechanism, and the conditions under which PMax actually pays off. This article does that.

How Performance Max Actually Works Across Surfaces

PMax runs ads across Search, Display, YouTube, Gmail, and Discover in one automated campaign. You provide assets (headlines, descriptions, images, videos, logos) and a conversion goal. Google allocates spend and picks placements using signals you cannot fully see or control. The trade is control for reach, and for lead-gen healthcare, that trade usually loses.

You cannot see which keywords PMax bid on. Search-term reports exist but are heavily filtered. You cannot separately report asset-group performance beyond high-level aggregates. You cannot exclude placements surgically the way you can in Search. You provide audience signals (not targeting, signals) that Google may or may not use.

The reach side is real. PMax will place ads in surfaces Search campaigns cannot reach. For brand-awareness businesses, that reach has value. For lead-gen practices that need to know exactly where qualified leads come from, the opacity is an operational problem. The weekly search-term review, the negative-keyword discipline, the account-level hygiene audit all assume control PMax does not give you.

PMax also competes with your own Search campaigns. Without explicit exclusions, PMax can bid on queries your Search campaigns are already winning, inflating CPCs in auctions you were paying less for. Most eye care accounts running PMax alongside Search have no exclusions configured.

What the Data Says About PMax vs. Search

The numbers that should inform the decision.

Independent Adalysis analysis: Search outperforms PMax on 84% of overlapping search terms (cited in Sandy Riev 2026 playbook, with underlying data from Q3 2024, flagged for age). This is the single most cited independent data point and remains directionally accurate despite the source age, because the mechanism (Search’s keyword-intent specificity against PMax’s blended surface optimization) has not changed in 2026, even as PMax matured and added new features like asset-group reporting.

Google’s own numbers: PMax claims 27% more conversions at similar CPA. For ecommerce, this is often real revenue. For lead-gen, the “more conversions” are frequently lower-quality form fills that never close. Unless you are measuring cost-per-qualified-lead instead of cost-per-form-fill, the 27% is misleading.

Healthcare lead-to-patient conversion rates often sit at 10–25% depending on specialty. That means 75–90% of the “conversions” PMax optimizes toward are not real patients. If your account is not closing the loop with Enhanced Conversions for Leads or offline conversion imports, the PMax algorithm is optimizing blind.

See the eye care PPC benchmarks reference for the CPC and CVR ranges PMax performance should be measured against.

Five Red Flags in Your Eye Care PMax Account

Five conditions that indicate PMax is draining more value than it is producing.

PMax is the primary lead-gen channel. If PMax spend exceeds Search spend for lead generation, the account is structured upside-down for healthcare. Search should be primary, PMax supplementary.

No campaign exclusions for brand terms. Without brand exclusions, PMax bids on searches for your practice name and inflates what should be $1–$3 brand CPCs. Every eye care PMax campaign needs brand-exclusion campaigns configured day one.

Asset group reporting not reviewed monthly. PMax exposes asset-group-level performance data, but most accounts never look at it. Without asset-group review, you cannot identify which creative is working and which is burning budget.

Qualified-lead optimization not set up. If the conversion goal is “form submitted” instead of “qualified lead” or “scheduled consult,” PMax is optimizing for the wrong outcome. This is the single most important PMax configuration and the one most often skipped.

PMax running alongside Search without exclusions. Without mutual exclusions, PMax and Search compete in the same auctions. Your own campaigns inflate each other’s CPCs, and the search-term cannibalization shows up in Auction Insights as rising overlap rates quarter over quarter. The 15-minute Google Ads audit surfaces this immediately. A practice running this configuration for six months is typically losing 15–25% of non-brand budget to internal auction competition it never sees.

How to Test PMax Without Burning Your Pipeline

PMax has a legitimate role as a scaling layer after Search is tuned. The test protocol that keeps the risk bounded.

Immediate, within 15 minutes: check whether PMax is running in your account, and if so, what percentage of total spend it represents. If it is above 30% of spend without CRM-validated lead-quality data, it is over-allocated. Immediate budget action: cap PMax at 20–30% of total spend until lead quality is proven.

Within 30 days: switch PMax optimization from form submission to a CRM-validated qualified-lead conversion. Implement Enhanced Conversions for Leads so hashed CRM identifiers flow back to Google. Configure brand exclusions. Review asset group reports weekly for placement waste.

Within 60–90 days: compare cost-per-qualified-lead for PMax vs. Search. If PMax holds CPA at the deeper conversion, it earns continued budget at the capped allocation. If PMax CPA drifts up or lead quality trends down, pull budget back to Search. The test has a 60-day window precisely because PMax takes 3–4 weeks to calibrate after optimization changes.

Document the decision. Whatever you conclude, write it down with the numbers. A later agency or marketing lead should be able to read the memo and understand why PMax is or is not in the account.

Why PMax Should Be a Supplement in Eye Care

Our view is direct. PMax works well for ecommerce. For healthcare lead generation, Search with tight control beats PMax in 84% of overlapping auctions (per independent data). The honest answer is to use PMax deliberately as a supplement, not as default.

Eye care practices that have been pushed into PMax as their primary lead channel are almost always under-performing vs. what a well-structured Search account would produce, and almost always unable to prove it because the measurement is not in place. The first step is closing the measurement loop. The second step is letting PMax’s performance at the deeper conversion decide whether it stays. The related platform shift, AI Max’s September 2026 migration, compounds the stakes, and the AI Max HIPAA governance question is a different-but-adjacent compliance problem every PMax-adjacent decision now touches.

For the complete audit framework covering PMax configuration, attribution, and the full set of surfaces an eye care account should be evaluated against, see the 2026 PPC Audit Playbook for Specialty Eye Care Practices.

If Google recommends moving our budget to PMax, should we?

Treat the recommendation as a suggestion, not instruction. Google optimizes for Google’s total spend share, which is not always your best interest. Test PMax with 15–20% of budget for 60 days, measure CRM-validated lead quality vs. Search, then decide. Auto-applying Google recommendations without testing is a common way to lose $20–50K on a slow-leak PMax campaign.

What if our competitor is crushing us with PMax?

They may not be. “Crushing us with PMax” usually means “showing up in more places.” Measure actual conversion volume to your CRM, not impression share. Many practices assume competitor PMax dominance based on seeing their ads, without data on whether those ads convert. Baseline your own performance before reacting to competitor surface-level activity.

Let's grow your practice

We're the marketing team behind specialty eye care practices that lead. Websites, SEO, content, video, social, ads — every layer run in-house by one team that only works in healthcare. Every site we've taken over has grown 25%+ organically.